Virtual Reality - A New Vision on Pain
CompletedNCT06045741
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of the project is to investigate if the use of virtual reality (VR) technology with pre-programmed proprietary software can provide better treatment for patients with long-term pain conditions. This is investigated in this pilot study conducted on patients referred to outpatient treatment at the Division of Physical Medicine and Rehabilitation. The pilot study will lay the foundation for a follow-up study (RCT). The effect of VR are evaluated by patient reporting forms; before start-up and 3 months after startup. Patients included in the study receive standard treatment supplemented with the use of VR technology. The therapists involved will be Interviewed to examine their experiences with the use of the VR-technology in the treatment of patients. VR technology can potentially contribute to better treatment (e.g. measured in outcomes such as activity, sleep problems, pain intensity, quality of life). Moreover we expect that a VR-assisted treatment to be more cost-effective and increased availability regardless of geography and demography.
Study details
- Official title
- Virtual Reality - A New Vision on Pain
- Conditions
- Chronic Pain
- Pain, Chronic
- Musculoskeletal Disorder
- Musculoskeletal Pain
- Musculoskeletal Diseases or Conditions
- Musculoskeletal Neck Pain
- Back Pain
- Sponsor
- Sykehuset i Vestfold HF
- Start date
- 2023-09-01
- Primary completion
- 2024-08-18
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Norway
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * pain duration \> 3 moths * Master Norwegian spoken language Exclusion Criteria: * History of malignant disease * pain duration \< 3 Months * Does not master Norwegian spoken language * Epilepsy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06045741